Christopher Peetz's Net Worth
$8.25 Million
Who is Christopher Peetz?
Christopher Peetz has an estimated net worth of $8.25 Million. This is based on reported shares across multiple companies, which include ALPINE IMMUNE SCIENCES, INC., Mirum Pharmaceuticals, Inc., and Regado Biosciences Inc.
SEC CIK
Christopher Peetz's CIK is 0001614740
Past Insider Trading and Trends
2021 was Christopher Peetz's most active year for acquiring shares with 7 total transactions. Christopher Peetz's most active month to acquire stocks was the month of December. 2021 was Christopher Peetz's most active year for disposing of shares, totalling 1 transactions. Christopher Peetz's most active month to dispose stocks was the month of January. 2021 saw Christopher Peetz paying a total of $160,688.86 for 216,778 shares, this is the most they've acquired in one year. In 2024 Christopher Peetz cashed out on 6,013 shares for a total of $157,491.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALPINE IMMUNE SCIENCES, INC. (ALPN) Snapshot price: $27.215
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4/A
|
∞
| 1.9K |
$10.17 | $19,323.00 | 1.9K |
Sep 23
| |||
Form 4
|
∞
| 1.9K |
$10.17 | $19,323.00 | 1.9K |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.809
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.31% | -5.16K |
$20.62 | -$106,390.45 | 91.95K |
Jan 9
| |||
Form 4
| -5.46% | -6.01K |
$26.19 | -$157,491.29 | 104.11K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| -4.52% | -5.21K |
$28.03 | -$146,033.27 | 110.13K |
Jan 8
| |||
Form 4
| -4.55% | -5.50K |
$25.65 | -$141,005.01 | 115.33K |
Jul 3
| |||
Form 4
| +1.05% | 1.26K |
$16.92 | $21,255.92 | 120.83K |
May 10
| |||
Form 4
| +71.86% | 50K |
—
|
—
| 119.58K |
Jan 31
| |||
Form 4
| +0.07% | 49 |
$17.05 | $835.50 | 69.58K |
Nov 10
| |||
Form 4
| +2.21% | 1.5K |
$13.57 | $20,349.00 | 69.53K |
May 10
| |||
Form 4
| +142.72% | 40K |
—
|
—
| 68.03K |
Jan 6
| |||
Form 4
| +33.29% | 7K |
$14.40 | $100,800.00 | 28.03K |
Nov 24
| |||
Form 4
| +644.58% | 18.2K |
$19.26 | -$70,708.03 | 21.03K |
Sep 29 - Oct 1
| |||
Form 4
| +105.98% | 1.45K |
$14.62 | $21,242.86 | 2.82K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +2.54% | 5K |
$18.70 | $93,480.00 | 201.57K |
Dec 23
| |||
Form 4
|
∞
| 1.37K |
$15.27 | $20,929.69 | 1.37K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +4.84% | 9.07K |
$11.02 | $99,937.88 | 196.57K |
Sep 6 - Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regado Biosciences Inc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||